Purchase of prolacta breastmilk products to support premature infants in the nicu at tripler army medical center
Ended Awarded
- Contract number
- HT009026FG1040072
- Awardee
-
Prolacta Bioscience, Inc. UEI VJUKD4ELEKD6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $35,818
Award facts
- Contract value 100% obligated
- $35,818.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- City of Industry, CA 91746, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $35,818.34 firm fixed price call under an existing Blanket Purchase Agreement to Prolacta Bioscience, Inc. for the purchase of human milk-based nutritional products to support premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract, which commenced on October 1, 2025, and extends through September 30, 2026, requires no set-aside designation. Prolacta Bioscience, headquartered in City of Industry, California, specializes in manufacturing advanced breastmilk-derived fortifiers, supplements, and donor human milk products specifically engineered to meet the complex nutritional needs of extremely low birth weight and premature infants. The products delivered under this call will support critical neonatal care operations within the military healthcare system.
This award represents a task order issued under one of three significant Blanket Purchase Agreements that the Defense Health Agency maintains with Prolacta Bioscience, including a $1.75 million BPA established in October 2022, a $500,000 BPA for donor human milk established in September 2023, and a $1.9 million BPA established in December 2024. These indefinite delivery vehicles enable the Defense Health Agency to procure specialized human milk-based nutritional products across multiple military medical facilities on a firm fixed price basis. Prolacta Bioscience's exclusive federal contract history with the Defense Health Agency underscores the specialized nature of these products and their critical importance to neonatal care delivery within the military healthcare system.
Quick answers
Who was awarded contract HT009026FG1040072?
HT009026FG1040072 was awarded to Prolacta Bioscience, Inc. by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT009026FG1040072 worth?
The government has obligated $35,818 on HT009026FG1040072.
Is contract HT009026FG1040072 an order under another contract?
Yes. HT009026FG1040072 is a BPA call under W81K0222A0010, a blanket purchase agreement.
Was contract HT009026FG1040072 competed?
The extent of competition for HT009026FG1040072 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award